Tag: National Institutes of Health
Vaxxas to develop first room-temperature stable RSV vaccine with NIH license
Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV).
3D-printed skin technology offers hope for wound healing and hair restoration
A recent breakthrough in 3D bioprinting technology has paved the way for the creation of multi-layered living skin with the potential to regenerate hair follicles.
MIT researchers develop 3D-printed heart that functions like a real one
Engineers at the Massachusetts Institute of Technology have devised a method for 3D printing a soft and flexible replica of a patient's heart in the hopes of helping doctors tailor treatments to patients’ specific heart form and function.
Featured Article
How growth capital is helping an Australian manufacturer go global
There’s a particular kind of ingenuity that flourishes in regional Australia. Away from the noise of major business centres, founders build companies that quietly become world leaders in their field, solving deep specialised problems that global markets didn’t know could be solved. Modra Technology, based in Warragul in regional Victoria, is one of those companies.
